Ai Eti Llc - Net Worth and Insider Trading

Ai Eti Llc Net Worth

The estimated net worth of Ai Eti Llc is at least $37 Million dollars as of 2024-05-27. Ai Eti Llc is the 10% Owner of Eliem Therapeutics Inc and owns about 5,009,400 shares of Eliem Therapeutics Inc (ELYM) stock worth over $37 Million. Details can be seen in Ai Eti Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ai Eti Llc has not made any transactions after 2021-08-12 and currently still holds the listed stock(s).

Transaction Summary of Ai Eti Llc

To

Ai Eti Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ai Eti Llc owns 1 companies in total, including Eliem Therapeutics Inc (ELYM) .

Click here to see the complete history of Ai Eti Llc’s form 4 insider trades.

Insider Ownership Summary of Ai Eti Llc

Ticker Comapny Transaction Date Type of Owner
ELYM Eliem Therapeutics Inc 2021-08-12 10 percent owner

Ai Eti Llc Latest Holdings Summary

Ai Eti Llc currently owns a total of 1 stock. Ai Eti Llc owns 5,009,400 shares of Eliem Therapeutics Inc (ELYM) as of August 12, 2021, with a value of $37 Million.

Latest Holdings of Ai Eti Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ELYM Eliem Therapeutics Inc 2021-08-12 5,009,400 7.41 37,119,654

Holding Weightings of Ai Eti Llc


Ai Eti Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Ai Eti Llc has made a total of 1 transactions in Eliem Therapeutics Inc (ELYM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eliem Therapeutics Inc is the acquisition of 800,000 shares on August 12, 2021, which cost Ai Eti Llc around $10 Million.

Insider Trading History of Ai Eti Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ai Eti Llc Trading Performance

GuruFocus tracks the stock performance after each of Ai Eti Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ai Eti Llc is 3.46%. GuruFocus also compares Ai Eti Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ai Eti Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ai Eti Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ai Eti Llc

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 49.88
Relative Return to S&P 500(%) 49.93

Ai Eti Llc Ownership Network

Ownership Network List of Ai Eti Llc

No Data

Ownership Network Relation of Ai Eti Llc


Ai Eti Llc Owned Company Details

What does Eliem Therapeutics Inc do?

Who are the key executives at Eliem Therapeutics Inc?

Ai Eti Llc is the 10 percent owner of Eliem Therapeutics Inc. Other key executives at Eliem Therapeutics Inc include Chief Accounting Officer Emily Pimblett , director & 10 percent owner Ra Capital Healthcare Fund Lp , and other: Affiliate of 10% Owner Len Blavatnik .

Eliem Therapeutics Inc (ELYM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eliem Therapeutics Inc (ELYM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eliem Therapeutics Inc (ELYM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eliem Therapeutics Inc (ELYM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eliem Therapeutics Inc Insider Transactions

No Available Data

Ai Eti Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Ai Eti Llc. You might contact Ai Eti Llc via mailing address: C/o Access Industries, Inc., 40 West 57th Street, 28th Floor, New York Ny 10019.

Discussions on Ai Eti Llc

No discussions yet.